Divi's Laboratories Limited FII & DII Activity
5-Day Flow Trend
| Date | FII Net (₹ Cr) | DII Net (₹ Cr) |
|---|---|---|
| 2026-09-04 | −3111.94 | +8930.12 |
| 2026-09-03 | −2345.87 | +4977.46 |
| 2026-09-02 | +6688.37 | +2812.98 |
| 2026-09-01 | −7985.88 | +4588.88 |
| 2026-08-31 | −7985.88 | +4588.88 |
Today's Institutional Flow
On 4 September 2026, foreign institutional investors (FII) posted a net cash outflow of ₹‑3,111.94 Cr, while domestic institutional investors (DII) recorded a net cash inflow of ₹ 8,930.12 Cr. The divergence underscores a strong domestic appetite versus a modest foreign retreat. Overall, the net institutional cash flow for the market stands at a positive ₹ 5,818.18 Cr for the day.
Trend vs 5‑Day Average
The FII cash outflow of ₹‑3,111.94 Cr is milder than the five‑day average outflow of ₹‑3,333.81 Cr, indicating a slight easing in foreign selling pressure. Conversely, the DII cash inflow of ₹ 8,930.12 Cr exceeds the five‑day average buying of ₹ 4,430.43 Cr, suggesting that domestic investors are accelerating their purchases relative to the recent norm.
F&O Positioning Data
FII futures‑and‑options (F&O) positions show a net long exposure of ₹ 374,795 Cr, reflecting continued confidence in equity market upside. The index futures long‑to‑short ratio for FIIs sits at 1.2, meaning long positions outweigh shorts by 20 percent.
Healthcare Sector Flow
The healthcare sector, where Divi’s Laboratories Limited operates, has experienced predominantly net buying from DII and modest selling from FII over the past week, reinforcing a domestic bias in sectoral flows.
Market-wide FII/DII data — same for all F&O stocks. Date: 2026-09-04